Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Interim profits, sales surge at Next but outlook cautious

(Sharecast News) - High street retailer Next posted a surge in earnings on Thursday, boosted by bumper international sales, sunny weather and disruption at Marks & Spencer. But the FTSE 100 group also sounded a more cautious note going forward, weighing on the shares.

Total group sales, which include discounted items, rose 10.3% in the six months to July 2025, to £3.2bn, while pre-tax profits rallied 13.8% at £515m. Full-price sales were up 10.9%.

The fashion and homewares retailer said it had enjoyed an especially strong second quarter.

In the UK - where it has around 460 stores - it benefited from both warm summer weather and disruption at rival M&S, which was hit by a major cyberattack.

International trading was also strong. Total international sales surged 28% in the first half, compared to an 8% uplift domestically.

However, looking to current trading, and Next forecast group sales would slow in the coming months.

It expects sales growth of 4.5% in the second half, putting it on track to grow sales by 7.5% over the whole year.

"In the UK, we believe we exceeded expectations in the second quarter, as a result of better summer weather and trading disruption at a major competitor," Next noted. "We do not expect either of these factors to have a material effect in the second half."

Full-year profit guidance was also left unchanged, at £1.1bn.

In comments accompanying the results, long-standing chief executive Simon Wolfson said: "With the worst of the structural shift from store to online trading behind us, the opportunities for change and growth now present themselves in virtually every area of the business."

But he also flagged "anaemic" economic growth in the UK.

He continued: "Progress [is] constrained by four factors: declining job opportunities, new regulation that erodes competitiveness, government spending commitments that are beyond its means and a rising tax burden that undermines national productivity."

As at 1100 BST, shares in the blue chip were down 5%, at 11,367p, as markets reacted to the more cautious outlook.

Russ Mould, investment director at AJ Bell, said: "Next has a reputation for straight talking, so its stark take on the prospects for the UK economy will carry weight."

But he continued: "It is worth rememberING that the company has got under-promising and over-delivering down to fine art, a key component of being a successful public company.

"While its share price has fallen, Next may not mind a little heat coming out of the stock, given it had been trading close to recent all-time highs. The group is clearly looking to give itself an easier bar to clear in the coming months by leaving full-year guidance unchanged, despite the first-half beat."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.